Every SEC Form 3/4/5 on record for this filer (CIK 1703723) — 5 issuers, 50 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RVTY | REVVITY, INC. | Director | 2023-05-17 → 2026-05-11 | 4 | — |
| RGLS | Regulus Therapeutics Inc. | Director | 2017-06-02 → 2025-06-27 | 19 | $32,000 |
| HZNP | Horizon Therapeutics Public Ltd Co | Director · lapsed | 2017-08-03 → 2023-10-06 | 13 | — |
| PKI | PERKINELMER INC | Director · lapsed | 2017-10-30 → 2022-05-09 | 9 | −$279,035 |
| TSRO | TESARO, Inc. | Director · lapsed | 2018-05-11 → 2019-01-22 | 4 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
1 of 5 issuers are covered and open a security page; the rest are on file here only.